Clustering data with hclust algorithm for (Study ST000082)

(Analysis AN000133)
MetaboliteStructureF1F2
LPC (o-16:0)ME6561802.330.93
LPC (p-18:0) or LPC (o-18:1)ME6561822.240.94
LPC (18:0)ME6561721.650.97
LPC (p-16:0) or LPC (o-16:1)ME6561811.920.95
SM (d40:2) AME6562670.981.00
TG (56:1)ME6563040.991.00
LPC (20:4)ME6561761.031.00
PC (p-34:1) or PC (o-34:2) AME6562261.021.00
TG (48:4)ME6562811.021.00
TG (56:0)ME6563031.001.00
plasmenyl-PE (38:4)ME6562461.011.00
PE (p-36:4) or PE (o-36:5)ME6562431.011.00
plasmenyl-PE (34:2)ME6562451.011.00
LPC (18:2)ME6561741.051.00
TG (58:1)ME6563111.041.00
PC (p-34:2) or PC (o-34:3)ME6562271.071.00
SM (d18:2/18:1)ME6562611.091.00
LPC (16:0)ME6561691.230.99
TG (60:3)ME6563181.240.99
PC (p-42:5) or PC (o-42:6)ME6562391.280.99
TG (58:3)ME6563141.260.99
LPC (20:1)ME6561751.180.99
TG (58:2)ME6563131.170.99
CE (18:2)ME6561531.120.99
1-Octadecanoyl-sn-glycero-3-phosphoethanolamineME6561411.140.99
TG (60:2)ME6563171.150.99
C16:1 acylcarnitineME6561500.271.04
TG (51:2)ME6562890.271.04
PC (32:1)ME6561920.291.04
TG (56:5)ME6563080.281.04
TG (60:11)ME6563160.281.04
C8:0 acylcarnitine;ME6561510.231.04
TG (44:1)ME6562740.241.04
Acylcarnitine C18:1ME6561460.261.04
C14:0 acylcarnitine;ME6561480.251.04
C14:1 acylcarnitine ;ME6561490.211.04
PC (38:8)ME6562140.211.04
Acetyl-L-carnitineME6561420.181.04
Acylcarnitine C10:0ME6561430.161.04
PC (34:4)ME6561990.501.03
PC (37:5)ME6562080.501.03
PC (p-40:6) or PC (o-40:7) AME6562360.481.03
Acylcarnitine C18:0ME6561450.481.03
LPC (20:5)ME6561770.481.03
TG (46:3)ME6562780.491.03
SM (d18:1/14:0)ME6562560.491.03
SM (d18:1/12:0)ME6562550.491.03
PC (18:1/16:0)ME6561870.491.03
PC (40:6) BME6562180.491.03
TG (56:3)ME6563060.451.03
TG (55:3)ME6563020.451.03
TG (50:0)ME6562830.451.03
TG (48:1)ME6562790.451.03
PC (40:7)ME6562190.451.03
PC (30:1)ME6561900.451.03
PC (38:6) AME6562130.451.03
TG (53:3)ME6562950.461.03
DG (36:2)ME6561620.461.03
TG (46:0)ME6562760.461.03
TG (54:2)ME6562980.471.03
SM (36:0)ME6562490.471.03
TG (46:2)ME6562770.471.03
PC (31:0)ME6561910.421.03
PC (35:1)ME6562000.441.03
HydromorphoneME6561660.441.03
PC (30:0)ME6561890.441.03
TG (52:1)ME6562910.431.03
PC (28:0)ME6561880.431.03
PC (34:3)ME6561980.431.03
TG (53:2)ME6562940.381.03
TG (49:0)ME6562820.401.03
TG (42:1)ME6562730.391.03
Ceramide (d42:2)ME6561570.391.03
PC (36:6) BME6562060.391.03
PE (38:6)ME6562420.361.03
TG (56:6)ME6563090.361.03
TG (51:1)ME6562880.351.03
TG (58:6)ME6563150.341.03
TG (42:0)ME6562720.311.04
SM (d43:2) AME6562700.331.03
PC (37:6)ME6562090.321.03
Acylcarnitine C16:0ME6561440.321.03
PC (33:1)ME6561940.321.03
TG (58:10)ME6563120.781.01
SM (d18:1/16:0)ME6562570.781.01
PC (p-38:2) or PC (o-38:3)ME6562300.781.01
LPC (22:6)ME6561790.781.01
PC (37:2)ME6562070.781.01
SM (d40:0)ME6562650.791.01
SM (d18:2/24:1)ME6562630.791.01
SM (d18:2/23:0)ME6562620.791.01
PC (p-32:0) or PC (o-32:1)ME6562240.791.01
SM (d16:1/20:1)ME6562530.791.01
SM (d18:2/14:0)ME6562600.751.01
PC (o-34:0)ME6562230.771.01
CreatineME6561600.761.01
PC (p-42:3) or PC (o-42:4)ME6562370.761.01
SM (d41:1)ME6562680.811.01
SM (d18:1/16:1)ME6562580.811.01
PC (p-40:3) or PC (o-40:4)ME6562330.811.01
DG (34:1)ME6561610.811.01
PC (34:2)ME6561970.811.01
PC (38:4)ME6562120.851.01
PC (40:5)ME6562160.841.01
PC (p-38:3) or PC (o-38:4)ME6562310.831.01
GlcCer (42:1)ME6561650.831.01
LPC (14:0)ME6561670.831.01
PC (p-36:2) or PC (o-36:3)ME6562280.941.00
SM (d42:1)ME6562690.951.00
plasmenyl-PE (38:5)ME6562470.881.01
lysoPC (20:3)ME6561830.881.01
PC (p-36:4) or PC (o-36:5)ME6562290.881.01
1-Linoleoyl-2-stearoyl-sn-glycero-3-phospho-(1^-sn-glycerol)ME6561400.871.01
SM (38:2)ME6562500.871.01
LPC (17:1)ME6561710.861.01
PC (36:2)ME6562040.861.01
LPC (22:5)ME6561780.911.00
PC (40:4)ME6562150.911.00
LPC (15:0)ME6561680.901.01
LPC (18:1)ME6561730.901.01
SM (d40:1)ME6562660.891.01
TG (57:2)ME6563100.891.01
PC (38:2)ME6562100.721.01
CholesterolME6561580.741.01
PC (40:8)ME6562200.741.01
PC (35:4)ME6562020.731.01
CholineME6561590.731.01
DG (36:3)ME6561630.731.01
TG (55:1)ME6563000.701.02
LPC (16:1)ME6561700.701.02
PC (42:5)ME6562220.701.02
SM (d16:1/20:0)ME6562520.681.02
PC (p-38:4) A or PC (o-38:5) AME6562320.681.02
PC (38:3)ME6562110.681.02
PC (34:0)ME6561960.681.02
PC (36:4)ME6562050.681.02
PC (p-42:4) or PC (o-42:5)ME6562380.691.02
PE (36:1)ME6562410.691.02
TG (53:4)ME6562960.661.02
TG (56:4)ME6563070.671.02
TG (56:2)ME6563050.671.02
TG (54:1)ME6562970.671.02
SM (d38:1)ME6562640.671.02
PC (p-40:4) or PC (o-40:5)ME6562340.671.02
Acylcarnitine C18:2ME6561470.671.02
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)ME6561640.671.02
SM (33:1)ME6562480.551.02
Ceramide (d40:1)ME6561550.571.02
TG (55:2)ME6563010.561.02
Ceramide (d18:1/23:0)ME6561540.561.02
TG (48:3)ME6562800.561.02
N-Tetracosenoyl-4-sphingenyl-1-O-phosphorylcholineME6561840.531.02
PC (32:2)ME6561930.541.02
TG (53:1)ME6562930.541.02
TG (50:2)ME6562840.511.02
TG (51:0)ME6562870.521.02
TG (44:2)ME6562750.521.02
PC (33:2)ME6561950.521.02
SM (d18:0/14:0)ME6562540.521.02
PC (p-44:4) or PC (o-44:5)ME6562400.601.02
PC (40:5) BME6562170.601.02
PC (36:1)ME6562030.601.02
CE (18:1)ME6561520.601.02
PC (16:0/9:0(CHO))ME6561860.601.02
PC (35:3)ME6562010.611.02
SM (d44:2)ME6562710.611.02
PC (p-40:5) or PC (o-40:6)ME6562350.581.02
SM (43:1)ME6562510.581.02
TG (52:0)ME6562900.591.02
TG (54:5)ME6562990.591.02
PC (p-34:0) or PC (o-34:1)ME6562250.641.02
TG (50:4)ME6562850.651.02
Ceramide (d42:1)ME6561560.651.02
plasmenyl-PC (36:3)ME6562440.651.02
TG (52:6)ME6562920.621.02
TG (50:5)ME6562860.631.02
SM (d18:1/21:0)ME6562590.631.02
PC (16:0/16:0)ME6561850.631.02
PC (42:10)ME6562210.631.02

Factors:

F1Source:Pooled Plasma
F2Source:Serum
Data matrix
  logo